Bank of New York Mellon Corp - DURATA THERAPEUTICS INC ownership

DURATA THERAPEUTICS INC's ticker is DRTX and the CUSIP is 26658A107. A total of 46 filers reported holding DURATA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$855,000
-62.8%
67,424
-50.0%
0.00%
Q2 2014$2,298,000
+183.7%
134,916
+124.4%
0.00%
Q1 2014$810,000
-0.5%
60,122
-5.5%
0.00%
Q4 2013$814,000
-7.3%
63,596
-34.5%
0.00%
Q3 2013$878,000
+149.4%
97,106
+98.7%
0.00%
Q2 2013$352,00048,8730.00%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
JAY JEFFREY R 639,433$4,604,0003.64%
Broadfin Capital, LLC 383,227$2,759,0000.54%
Orbimed Advisors 1,785,714$12,857,0000.27%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 752,539$5,418,0000.26%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 1,188,571$8,558,0000.09%
Lenox Wealth Advisors, LLC 8,000$58,0000.06%
Loeb Offshore Management LP 15,000$108,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 19,347$139,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,500$342,0000.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 63,100$454,0000.01%
View complete list of DURATA THERAPEUTICS INC shareholders